430 related articles for article (PubMed ID: 26719327)
1. Amyloid-β Receptors: The Good, the Bad, and the Prion Protein.
Jarosz-Griffiths HH; Noble E; Rushworth JV; Hooper NM
J Biol Chem; 2016 Feb; 291(7):3174-83. PubMed ID: 26719327
[TBL] [Abstract][Full Text] [Related]
2. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
[TBL] [Abstract][Full Text] [Related]
3. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
Bove-Fenderson E; Urano R; Straub JE; Harris DA
J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
[TBL] [Abstract][Full Text] [Related]
4. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
Smith LM; Kostylev MA; Lee S; Strittmatter SM
J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Um JW; Strittmatter SM
Prion; 2013; 7(1):37-41. PubMed ID: 22987042
[TBL] [Abstract][Full Text] [Related]
6. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
[TBL] [Abstract][Full Text] [Related]
7. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
Kino R; Araya T; Arai T; Sohma Y; Kanai M
Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
[TBL] [Abstract][Full Text] [Related]
8. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease.
Jang JY; Rhim H; Kang S
Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.
Kam TI; Gwon Y; Jung YK
Cell Mol Life Sci; 2014 Dec; 71(24):4803-13. PubMed ID: 25151011
[TBL] [Abstract][Full Text] [Related]
10. A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta.
Hilt S; Altman R; Kálai T; Maezawa I; Gong Q; Wachsmann-Hogiu S; Jin LW; Voss JC
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103547
[TBL] [Abstract][Full Text] [Related]
11. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
Bate C; Williams A
Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
[TBL] [Abstract][Full Text] [Related]
12. Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier.
Pflanzner T; Petsch B; André-Dohmen B; Müller-Schiffmann A; Tschickardt S; Weggen S; Stitz L; Korth C; Pietrzik CU
J Cereb Blood Flow Metab; 2012 Apr; 32(4):628-32. PubMed ID: 22293988
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
14. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
15. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
16. Structural and mechanistic commonalities of amyloid-β and the prion protein.
Da Costa Dias B; Jovanovic K; Gonsalves D; Weiss SF
Prion; 2011; 5(3):126-37. PubMed ID: 21862871
[TBL] [Abstract][Full Text] [Related]
17. Distinct types of amyloid-β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease.
Madhu P; Mukhopadhyay S
J Cell Biochem; 2021 Nov; 122(11):1594-1608. PubMed ID: 34494298
[TBL] [Abstract][Full Text] [Related]
18. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.
Kudo W; Petersen RB; Lee HG
Prion; 2013; 7(2):114-6. PubMed ID: 23154635
[TBL] [Abstract][Full Text] [Related]
19. Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.
Forest KH; Nichols RA
Trends Mol Med; 2019 Aug; 25(8):685-695. PubMed ID: 31248781
[TBL] [Abstract][Full Text] [Related]
20. Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease.
Khambete MP; Khare LP; Kapadia AB; Degani MS
Drug Metab Pers Ther; 2020 Aug; 35(3):. PubMed ID: 32776895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
